Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Sunday, October 1, 2006

A recent warning issued by the FDA cautions health care providers regarding a potential interaction between lowdose aspirin and ibuprofen. Ex vivo studies have shown that ibuprofen interferes with the antiplatelet effects of aspirin (81 mg immediate-release). This interaction appears to be most significant when ibuprofen is taken within 30 minutes after taking aspirin. The FDA states in the warning:

  • Occasional use of ibuprofen is likely to cause minimal risk
  • Spacing of ibuprofen at least 30 minutes after, or more than 8 hours before, aspirin ingestion is suggested
  • This problem exists only with immediate-release aspirin.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues